Medscape One

Sales & Marketing

Medscape One (M1) is a sophisticated, AI-powered decision engine designed to redefine HCP engagement.

News

Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.